Decoding Cancer with AI

Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravelled molecular secrets hidden in cancers using PandaOmics, an AI-driven target discovery platform. The team explored gene expression changes in rare DNA repair-deficient disorders to identify novel cancer targets. The findings provide important insights on the path to developing personalized cancer therapies.